[1] ZINCHUK V, ZHADKO D. Association of endothelial nitric oxide synthase gene G894T polymorphism with blood oxygen transport [J]. Nitric Oxide, 2019, 84:45-49.
[2] ZHU B, SI X, GONG Y, et al. An association between the endothelial nitric oxide synthase gene G894T polymorphism and premature coronary artery disease: a meta-analysis [J]. Oncotarget, 2017, 8(44):77990-77998.
[3] WITTKE-THOMPSON J K, PLUZHNIKOV A, COX N J. Rational inferences about departures from Hardy-Weinberg equilibrium[J]. Am J Hum Genet, 2005,76(6):967-986.
[4] SAHARA M, IKUTOMI M, MORITA T, et al. Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation [J]. Cardiovasc Res, 2014, 101(2):236-246.
[5] AUTRY A E, MONTEGGIA L M. Brain-derived neurotrophic factor and neuropsychiatric disorders [J]. Pharmacol Rev, 2012, 64(2):238-258.
[6] DUMAN R S, MONTEGGIA L M. Aneurotrophic model for stress-related mood disorders [J]. Biol Psychiatry, 2006, 59(12):1116-1127.
[7] MOLENDIJK M L, SPINHOVEN P, POLAK M, et al. Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N=9484) [J]. Mol Psychiatry, 2014,19(7):791-800.
[8] Circulating brain-derived neurotrophic factor concentrations and the risk of cardiovascular disease in the community [J]. J Am Heart Assoc, 2016, 5(7):e002098.
[9] SULTAN C S, WEITNAUER M, TURINSKY M, et al. Functional association of a CD40 gene single-nucleotide polymorphism with the pathogenesis of coronary heart disease [J]. Cardiovasc Res, 2020, 116(6):1214-1225.
[10] HENN V, SLUPSKY J R, GRÄFE M, et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells [J]. Nature, 1998, 391(6667):591-594.
[11] NEUBAUER H, PETRAK F, ZAHN D, et al. Newly diagnosed depression is associated with increased beta-thromboglobulin levels and increased expression of platelet activation markers and platelet derived CD40-CD40L [J]. J Psychiatr Res, 2013, 47(7):865-871.
[12] HADDAD Y, HEGER Z, ADAM V. Guidelines for homology modeling of dopamine, norepinephrine, and serotonin transporters [J]. ACS Chem Neurosci, 2016, 7(11):1607-1613.
[13] KARAKUS O O, GODUGU K, RAJABI M, et al. Dualtargeting of norepinephrine transporter (NET) function and thyrointegrin αvβ3 receptors in the treatment of neuroblastoma [J]. J Med Chem, 2020, 63(14):7653-7662.
[14] PANDIT-TASKAR N, MODAK S. Norepinephrine transporter as a target for imaging and therapy [J]. J Nucl Med, 2017, 58(Suppl 2):39S-53S.
[15] OLLMANN T M, VOSS C, VENZ J, et al. The interaction of 5-HTT variation, recent stress, and resilience on current anxiety levels in adolescents and young adults from the general population [J]. Depress Anxiety, 2021, 38(3):318-327.
[16] BELLANI M, NOBILE M, BIANCHI V, et al. G × E interaction and neurodevelopment II. Focus on adversities in paediatric depression: the moderating role of serotonin transporter [J]. Epidemiol Psychiatr Sci, 2013, 22(1):21-28.
[17] SOSLAU G. Cardiovascular serotonergic system: evolution, receptors, transporter, and function [J]. J Exp Zool A Ecol Integr Physiol, 2022, 337(2):115-127. |
